405 related articles for article (PubMed ID: 29518087)
1. Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model.
Sugiura H; Matsushita A; Futaya M; Teraoka A; Akiyama KI; Usui N; Nagano N; Nitta K; Tsuchiya K
PLoS One; 2018; 13(3):e0191706. PubMed ID: 29518087
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and type II sodium-dependent phosphate cotransporters.
Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
[TBL] [Abstract][Full Text] [Related]
3. Regulation of fibroblast growth factor 23 production in bone in uremic rats.
Saji F; Shiizaki K; Shimada S; Okada T; Kunimoto K; Sakaguchi T; Hatamura I; Shigematsu T
Nephron Physiol; 2009; 111(4):p59-66. PubMed ID: 19339809
[TBL] [Abstract][Full Text] [Related]
4. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.
Gattineni J; Bates C; Twombley K; Dwarakanath V; Robinson ML; Goetz R; Mohammadi M; Baum M
Am J Physiol Renal Physiol; 2009 Aug; 297(2):F282-91. PubMed ID: 19515808
[TBL] [Abstract][Full Text] [Related]
5. Inflammation both increases and causes resistance to FGF23 in normal and uremic rats.
Rodríguez-Ortiz ME; Díaz-Tocados JM; Muñoz-Castañeda JR; Herencia C; Pineda C; Martínez-Moreno JM; Montes de Oca A; López-Baltanás R; Alcalá-Díaz J; Ortiz A; Aguilera-Tejero E; Felsenfeld A; Rodríguez M; Almadén Y
Clin Sci (Lond); 2020 Jan; 134(1):15-32. PubMed ID: 31860056
[TBL] [Abstract][Full Text] [Related]
6. Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia.
Mace ML; Gravesen E; Nordholm A; Hofman-Bang J; Secher T; Olgaard K; Lewin E
Kidney Int; 2017 Jul; 92(1):165-178. PubMed ID: 28341272
[TBL] [Abstract][Full Text] [Related]
7. Magnesium stimulates renal phosphate reabsorption.
Thumfart J; Jung S; Amasheh S; Krämer S; Peters H; Sommer K; Biber J; Murer H; Meij I; Querfeld U; Wagner CA; Müller D
Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1126-33. PubMed ID: 18701629
[TBL] [Abstract][Full Text] [Related]
8. Mutant FGF23 prevents the progression of chronic kidney disease but aggravates renal osteodystrophy in uremic rats.
Kusano K; Saito H; Segawa H; Fukushima N; Miyamoto K
J Nutr Sci Vitaminol (Tokyo); 2009 Apr; 55(2):99-105. PubMed ID: 19436134
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH.
Saji F; Shigematsu T; Sakaguchi T; Ohya M; Orita H; Maeda Y; Ooura M; Mima T; Negi S
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1212-7. PubMed ID: 20739393
[TBL] [Abstract][Full Text] [Related]
10. Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease.
Spichtig D; Zhang H; Mohebbi N; Pavik I; Petzold K; Stange G; Saleh L; Edenhofer I; Segerer S; Biber J; Jaeger P; Serra AL; Wagner CA
Kidney Int; 2014 Jun; 85(6):1340-50. PubMed ID: 24402093
[TBL] [Abstract][Full Text] [Related]
11. miR-129 Blocks Secondary Hyperparathyroidism-Inducing Fgf23/αKlotho Signaling in Mice with Chronic Kidney Disease.
Xu M; Li H; Bai Y; He J; Chen R; An N; Li Y; Dong Y
Am J Med Sci; 2021 May; 361(5):624-634. PubMed ID: 33781552
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.
Stubbs JR; He N; Idiculla A; Gillihan R; Liu S; David V; Hong Y; Quarles LD
J Bone Miner Res; 2012 Jan; 27(1):38-46. PubMed ID: 22031097
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo.
Küng CJ; Haykir B; Schnitzbauer U; Egli-Spichtig D; Hernando N; Wagner CA
Am J Physiol Renal Physiol; 2021 Dec; 321(6):F785-F798. PubMed ID: 34719948
[TBL] [Abstract][Full Text] [Related]
14. Effect of hydrolysis-resistant FGF23-R179Q on dietary phosphate regulation of the renal type-II Na/Pi transporter.
Segawa H; Kawakami E; Kaneko I; Kuwahata M; Ito M; Kusano K; Saito H; Fukushima N; Miyamoto K
Pflugers Arch; 2003 Aug; 446(5):585-92. PubMed ID: 12851820
[TBL] [Abstract][Full Text] [Related]
15. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.
Carrillo-López N; Panizo S; Alonso-Montes C; Martínez-Arias L; Avello N; Sosa P; Dusso AS; Cannata-Andía JB; Naves-Díaz M
Nephrol Dial Transplant; 2019 Jun; 34(6):934-941. PubMed ID: 30189026
[TBL] [Abstract][Full Text] [Related]
16. The regulation of FGF23 under physiological and pathophysiological conditions.
Rausch S; Föller M
Pflugers Arch; 2022 Mar; 474(3):281-292. PubMed ID: 35084563
[TBL] [Abstract][Full Text] [Related]
17. Fortified phosphorus‑lowering treatment through administration of lanthanum protects against vascular calcification via regulation of FGF23 in chronic kidney disease.
Jiang J; Li Y; Zheng D; Wang Z; Zhou H; Liu G
Int J Mol Med; 2020 Nov; 46(5):1783-1793. PubMed ID: 32901861
[TBL] [Abstract][Full Text] [Related]
18. Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease.
Kawakami K; Takeshita A; Furushima K; Miyajima M; Hatamura I; Kuro-O M; Furuta Y; Sakaguchi K
Sci Rep; 2017 Jan; 7():40534. PubMed ID: 28094278
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
Koizumi M; Komaba H; Fukagawa M
Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
[TBL] [Abstract][Full Text] [Related]
20. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
